Home / articles / Bioimpedance Evaluation of Body Fat Composition in Congolese HIV-Infected Patients under Antiretroviral Therapy Regimen Non-Containing Protease Inhibitors nor Stavudine

Bioimpedance Evaluation of Body Fat Composition in Congolese HIV-Infected Patients under Antiretroviral Therapy Regimen Non-Containing Protease Inhibitors nor Stavudine

Jean-Robert Rissassy Makulo1,2*, Djuma Lukonga1, Augustin Luzayadio Longo1,2, Jean De Dieu Manyebwa1,3, Tresor Monsere1,2, Ernest Kiswaya Sumaili1,2,
Hippolyte Nanituma Situakibanza1,3, Jean Bosco Lasi Kasiam1,4, Roger Mwimba Mbungu1,5, Jean-Marie Ntumba Kayembe1,6 and Francois Bompeka Lepira1,2


1Faculty of Medicine, University of Kinshasa, DR Congo
2Nephrology Unit, Department of Internal Medicine, University Clinics of Kinshasa, University of Kinshasa, DR Congo
3Infectious Diseases Unit, Department of Internal Medicine, University Clinics of Kinshasa, University of Kinshasa, DR Congo
4Endocrinology and Metabolic Diseases Unit, Department of Internal Medicine, University Clinics of Kinshasa, University of Kinshasa, DR Congo
5Department of Gynecology and Obstetrics, University Clinics of Kinshasa, University of Kinshasa, DR Congo
6Pneumology Unit, Department of Internal Medicine, University Clinics of Kinshasa, University of Kinshasa, DR Congo


J Metabolic Synd
ISSN:2167-0943 JMS, an open access journal

Volume 3 • Issue 5 • 1000168


Abstract

Background: Protease inhibitors (PI) and stavudine are frequently associated with abnormalities of the body composition. The present study aimed to evaluate the body fat composition of HIV-infected Congolese patients receiving antiretroviral other than PI or stavudine.
Patients and Methods: Anthropometric measures and body composition of 125 HIV-infected Congolese patients (average age 41 years, 76% women, 74% on antiretroviral therapy) attending a primary healthcare center was cross-sectionally evaluated. Patients receiving PI and/or stavudine were excluded. Subclinical abnormalities of body composition, evaluated by bioimpedance (BIA), were defined as elevated percentage of fat mass (FM) and
perivisceral fat mass (PVF) and low percentage of total FM.
Results: Clinically evaluated abnormalities of fat distribution were rarely seen, with any case of obesity or lipodystrophy. Overweight (16%) and central obesity (6.3%) were present only in a few women. BIA parameters of body fat composition were similar among antiretroviral naive and treated patients. An average higher percentage of FM (28% vs. 12.1%; p<0.001) and PVF (4.0% vs. 2.3%; p=0.002) were observed in women, with as well as a higher proportion of subjects with high levels of FM (12.6%) and PVF (2.2%) in the same group. Thinness was observed only in 6% of patients of  whom 83.3% of men and 68.4% of women (p=0.059) had low levels of FM.
Conclusion: Subclinical abnormalities of FM were present in these case series without clinically overt fat distribution abnormalities, highlighting the need for early detection of these FM abnormalities.

bioimpedance-evaluation-of-body-fat-composition-in-congolese-hivinfected-patients-under-antiretroviral-therapy-regimen-noncontaining-protease-inhibitors-nor-stavudine-2167-0943.1000168.pdf (8 téléchargements)

Laisser un commentaire

Votre adresse de messagerie ne sera pas publiée. Les champs obligatoires sont indiqués avec *

Haut